Oncogene - Table of Contents alert Volume 32 Issue 23

TABLE OF CONTENTS Volume 32, Issue 23 (June 2013) In this issue Review Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Take part in our reader survey for a chance to win a MacBook Air As a reader of NPG's clinical and society-owned journals, we invite you to take part in a survey on your use of our journals and their associated websites. Take the survey and be entered into a prize draw for a MacBook Air* *Terms & conditions apply      Review Top The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia S N Malek Oncogene 2013 32: 2805-2817; advance online publication, September 24, 2012; 10.1038/onc.2012.411 Abstract | Full Text Original Articles Top Real-time imaging of the dynamics of death receptors and therapeutics that overcome TRAIL resistance in tumors T Bagci-Onder, A Agarwal, D Flusberg, S Wanningen, P Sorger and K Shah Oncogene 2013 32: 2818-2827; advance online publication, July 23, 2012; 10.1038/onc.2012.304 Abstract | Full Text HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockade Y J Kim, C B Greer, K R Cecchini, L N Harris, D P Tuck and T H Kim Oncogene 2013 32: 2828-2835; advance online publication, February 25, 2013; 10.1038/onc.2013.32 Abstract | Full Text Carboxypeptidase E: a negative regulator of the canonical Wnt signaling pathway N Skalka, M Caspi, E Caspi, Y P Loh and R Rosin-Arbesfeld Oncogene 2013 32: 2836-2847; advance online publication, July 23, 2012; 10.1038/onc.2012.308 Abstract | Full Text Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway L Adesso, S Calabretta, F Barbagallo, G Capurso, E Pilozzi, R Geremia, G Delle Fave and C Sette Oncogene 2013 32: 2848-2857; advance online publication, July 16, 2012; 10.1038/onc.2012.306 Abstract | Full Text Annexin A6 is a scaffold for PKCα to promote EGFR inactivation M Koese, C Rentero, B P Kota, M Hoque, R Cairns, P Wood, S Vilà de Muga, M Reverter, A Alvarez-Guaita, K Monastyrskaya, W E Hughes, A Swarbrick, F Tebar, R J Daly, C Enrich and T Grewal Oncogene 2013 32: 2858-2872; advance online publication, July 16, 2012; 10.1038/onc.2012.303 Abstract | Full Text Oncogenic RAS simultaneously protects against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR signaling blockade S Kasper, F Breitenbuecher, H Reis, S Brandau, K Worm, J Köhler, A Paul, T Trarbach, K W Schmid and M Schuler Oncogene 2013 32: 2873-2881; advance online publication, July 16, 2012; 10.1038/onc.2012.302 Abstract | Full Text The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial–mesenchymal transition and invasive properties of prostate cancer T Ezponda, R Popovic, M Y Shah, E Martinez-Garcia, Y Zheng, D-J Min, C Will, A Neri, N L Kelleher, J Yu and J D Licht Oncogene 2013 32: 2882-2890; advance online publication, July 16, 2012; 10.1038/onc.2012.297 Abstract | Full Text Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer T Hulf, T Sibbritt, E D Wiklund, K Patterson, J Z Song, C Stirzaker, W Qu, S Nair, L G Horvath, N J Armstrong, J G Kench, R L Sutherland and S J Clark Oncogene 2013 32: 2891-2899; advance online publication, August 6, 2012; 10.1038/onc.2012.300 Abstract | Full Text Short Communication Top The gain of function of p53 cancer mutant in promoting mammary tumorigenesis X Lu, D P Liu and Y Xu Oncogene 2013 32: 2900-2906; advance online publication, July 23, 2012; 10.1038/onc.2012.299 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.